울트라제닉스 파마슈티컬 (RARE)

06:38 AM

Published on: 2025-11-04 05:38:55 - newser.com

06:38 AM

05:55 AM

Is Ultragenyx Pharmaceutical Inc. stock attractive for long term wealth buildingQuarterly Earnings Summary & Weekly Watchlist for Hot Stocks - newser.com

05:55 AM

05:15 AM

Will Ultragenyx Pharmaceutical Inc. (UP0) stock hit Wall Street targetsJuly 2025 Technicals & Real-Time Volume Analysis Alerts - newser.com

05:15 AM

04:09 AM

Can Ultragenyx Pharmaceutical Inc. rally from current levelsM&A Rumor & Safe Entry Trade Reports - newser.com

04:09 AM

03:42 AM

Is it too late to sell Ultragenyx Pharmaceutical Inc.IPO Watch & Community Verified Trade Signals - newser.com

03:42 AM

01:46 AM

Will Ultragenyx Pharmaceutical Inc. stock remain a Wall Street favorite - newser.com

01:46 AM

Nov 03, 2025

Dosing begins in broader trial of Angelman syndrome therapy - Angelman Syndrome News

Nov 03, 2025

Nov 03, 2025

Key metrics from Ultragenyx Pharmaceutical Inc.’s quarterly data2025 Market Overview & Technical Pattern Based Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Why Ultragenyx Pharmaceutical Inc. stock appeals to dividend seekersJuly 2025 Price Swings & Weekly Breakout Stock Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Earnings visualization tools for Ultragenyx Pharmaceutical Inc.2025 Support & Resistance & Weekly Momentum Picks - newser.com

Nov 03, 2025

Nov 03, 2025

Can Ultragenyx Pharmaceutical Inc. (UP0) stock surprise with quarterly results2025 Volume Leaders & Low Drawdown Momentum Trade Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Can Ultragenyx Pharmaceutical Inc. (UP0) stock hold up in economic slowdownQuarterly Performance Summary & Daily Volume Surge Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Is this a good reentry point in Ultragenyx Pharmaceutical Inc.July 2025 Market Mood & Fast Exit and Entry Strategy Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Is Ultragenyx Pharmaceutical Inc. stock a buy in volatile marketsAnalyst Downgrade & Community Verified Watchlist Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Pinnacle Associates Ltd. Sells 29,107 Shares of Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

Nov 03, 2025

Nov 03, 2025

Chart based analysis of Ultragenyx Pharmaceutical Inc. trends - newser.com

Nov 03, 2025

Nov 03, 2025

Is Ultragenyx Pharmaceutical Inc. still worth holding after the dipTrade Volume Summary & Verified Chart Pattern Trade Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Is Ultragenyx Pharmaceutical Inc. stock a top momentum playTrade Entry Summary & High Yield Equity Trading Tips - newser.com

Nov 03, 2025

Nov 02, 2025

Can Ultragenyx Pharmaceutical Inc. stock sustain revenue growthJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com

Nov 02, 2025

Nov 02, 2025

How risky is Ultragenyx Pharmaceutical Inc. stock nowJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com

Nov 02, 2025

Nov 02, 2025

Can Ultragenyx Pharmaceutical Inc. stock deliver sustainable ROEJuly 2025 Short Interest & Long-Term Growth Plans - newser.com

Nov 02, 2025

Nov 02, 2025

Is Ultragenyx Pharmaceutical Inc. stock attractive after correctionWatch List & Long Hold Capital Preservation Plans - newser.com

Nov 02, 2025

Nov 02, 2025

Y Intercept Hong Kong Ltd Grows Stake in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

Nov 02, 2025

Nov 02, 2025

Is Ultragenyx Pharmaceutical Inc. stock dividend yield sustainablePortfolio Performance Report & Long-Term Investment Growth Plans - newser.com

Nov 02, 2025

Nov 01, 2025

Will Ultragenyx Pharmaceutical Inc. see short term momentum2025 Winners & Losers & Weekly Setup with High ROI Potential - newser.com

Nov 01, 2025

Nov 01, 2025

Will Ultragenyx Pharmaceutical Inc. stock benefit from upcoming earnings reports2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com

Nov 01, 2025

Oct 31, 2025

Ultragenyx Pharmaceutical Inc expected to post a loss of $1.23 a shareEarnings Preview - TradingView

Oct 31, 2025

Oct 31, 2025

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Exelixis (EXEL) - The Globe and Mail

Oct 31, 2025

Oct 31, 2025

Ultragenyx doses first subject in study of GTX-102 for angelman syndrome - Clinical Trials Arena

Oct 31, 2025

Oct 31, 2025

What hedge fund moves indicate for Ultragenyx Pharmaceutical Inc. (UP0) stockTreasury Yields & Daily Oversold Stock Bounce Ideas - newser.com

Oct 31, 2025

Oct 31, 2025

Emerald Mutual Fund Advisers Trust Trims Stock Holdings in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

Oct 31, 2025

Oct 31, 2025

Can Ultragenyx Pharmaceutical Inc. stock weather global recessionJuly 2025 Market Mood & Verified Technical Trade Signals - newser.com

Oct 31, 2025